✦ LIBER ✦

High-Dose Topotecan, Melphalan, and Cyclophosphamide (TMC) with Stem Cell Support: A New Regimen for the Treatment of Advanced Ovarian Cancer

✍ Scribed by Michele L. Donato; David M. Gershenson; James T. Wharton; Cindy M. Ippoliti; Ana S. Aleman; Diane Bodurka-Bevers; Michael W. Bevers; Thomas W. Burke; Charles F. Levenback; Judith K. Wolf; Ralph S. Freedman; Robert C. Bast Jr.; James L. Gajewski; Richard E. Champlin

Book ID: 112248617
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 65 KB
Volume: 82
Category: Article
ISSN: 0090-8258
DOI: 10.1006/gyno.2001.6326

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose chemotherapy with autologous s

High-dose chemotherapy with autologous stem cell support for the treatment of advanced ovarian cancer — initial experience in Uppsala and Turku

✍ Seija Grenman; Bengt Tholander; Kari Remes; Marjut Kauppila; Allan Rajamäki; Tar 📂 Article 📅 1997 🏛 Informa plc 🌐 English ⚖ 560 KB

Phase I/II trial of multicycle high-dose

Phase I/II trial of multicycle high-dose chemotherapy with peripheral blood stem cell support for treatment of advanced ovarian cancer

✍ Frickhofen, N; Berdel, W E; Opri, F; Haas, R; Schneeweiss, A; Sandherr, M; Kuhn, 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 140 KB

High dose, dose-intensive chemotherapy w

High dose, dose-intensive chemotherapy with Doxorubicin and Cyclophosphamide for the treatment of advanced breast cancer

✍ Ferguson, J.E.; Dodwell, D.J.; Seymour, A-M.; Richards, M.A.; Howell, A. 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 169 KB

High dose chemotherapy with autologous s

High dose chemotherapy with autologous stem cell support for the treatment of metastatic breast cancer

✍ Lois J. Ayash 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB 👁 1 views

Pilot Evaluation of High-Dose Carboplati

Pilot Evaluation of High-Dose Carboplatin and Paclitaxel Followed by High-Dose Melphalan Supported by Peripheral Blood Stem Cells in Previously Untreated Advanced Ovarian Cancer: A Gynecologic Oncology Group Study

✍ Russell J. Schilder; Mark F. Brady; David Spriggs; Thomas Shea 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 56 KB

A phase I–II study of high-dose melphala

A phase I–II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinoma

✍ Weaver, C H; Greco, F A; Hainsworth, J D; Zhen, B; Baldwin, P; Wittlin, F; Lewis 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 89 KB